Evidence map›Paper›PMID 30571745›Full record

ArticlePloS one2018

Protective effects of voltage-gated calcium channel antagonists against zinc toxicity in SN56 neuroblastoma cholinergic cells.

Marlena Zyśk, Beata Gapys, Anna Ronowska, Sylwia Gul-Hinc, Anna Erlandsson, Adam Iwanicki, Monika Sakowicz-Burkiewicz, Andrzej Szutowicz, Hanna Bielarczyk

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. The cAMP Inducers ModifyAntioxidants (Basel, Switzerland) · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Marlena ZyśkDepartment of Laboratory Medicine, Medical University of Gdansk, Gdansk, Poland.ORCID 0000-0002-0270-2503
Beata GapysDepartment of Laboratory Medicine, Medical University of Gdansk, Gdansk, Poland.
Anna RonowskaDepartment of Laboratory Medicine, Medical University of Gdansk, Gdansk, Poland.
Sylwia Gul-HincDepartment of Laboratory Medicine, Medical University of Gdansk, Gdansk, Poland.
Anna ErlandssonDepartment of Public Health & Caring Sciences/Molecular Geriatrics, Uppsala University, Uppsala, Sweden.
Adam IwanickiDepartment of Molecular Bacteriology, University of Gdańsk & Medical University of Gdańsk, Gdansk, Poland.
Monika Sakowicz-BurkiewiczDepartment of Molecular Medicine, Medical University of Gdansk, Gdansk, Poland.
Andrzej SzutowiczDepartment of Laboratory Medicine, Medical University of Gdansk, Gdansk, Poland.
Hanna BielarczykDepartment of Laboratory Medicine, Medical University of Gdansk, Gdansk, Poland.
Gdańsk Medical University · PLUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the pathological site effects in excitotoxic activation is Zn2+ overload to postsynaptic neurons. Such an effect is considered to be equivalent to the glutamate component of excitotoxicity. Excessive uptake of Zn2+ by active voltage-dependent transport systems in these neurons may lead to significant neurotoxicity. The aim of this study was to investigate whether and which antagonists of the voltage gated calcium channels (VGCC) might modify this Zn2+-induced neurotoxicity in neuronal cells. Our data demonstrates that depolarized SN56 neuronal cells may take up large amounts of Zn2+ and store these in cytoplasmic and mitochondrial sub-fractions. The mitochondrial Zn2+ excess suppressed pyruvate uptake and oxidation. Such suppression was caused by inhibition of pyruvate dehydrogenase complex, aconitase and NADP-isocitrate dehydrogenase activities, resulting in the yielding of acetyl-CoA and ATP shortages. Moreover, incoming Zn2+ increased both oxidized glutathione and malondialdehyde levels, known parameters of oxidative stress. In depolarized SN56 cells, nifedipine treatment (L-type VGCC antagonist) reduced Zn2+ uptake and oxidative stress. The treatment applied prevented the activities of PDHC, aconitase and NADP-IDH enzymes, and also yielded the maintenance of acetyl-CoA and ATP levels. Apart from suppression of oxidative stress, N- and P/Q-type VGCCs presented a similar, but weaker protective influence. In conclusion, our data shows that in the course of excitotoxity, impairment to calcium homeostasis is tightly linked with an excessive neuronal Zn2+ uptake. Hence, the VGCCs types L, N and P/Q share responsibility for neuronal Zn2+ overload followed by significant energy-dependent neurotoxicity. Moreover, Zn2+ affects the target tricarboxylic acid cycle enzymes, yields acetyl-CoA and energy deficits as well.

Indexed as

AnimalsCalciumCalcium Channel BlockersCalcium Channels, L-TypeCalcium Channels, N-TypeCations, DivalentCell Line, TumorCell SurvivalCholinergic NeuronsEnergy MetabolismMiceMitochondriaNeuroblastomaNeurotoxinsNifedipineZincCalciumCalcium Channel BlockersCalcium Channels, L-TypeCalcium Channels, N-TypeCations, DivalentNeurotoxinsNifedipineZinc

Identifiers

PMID30571745
PMCPMC6301650
OpenAlexW2906221343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.